نتایج جستجو برای: containing vaginal gel

تعداد نتایج: 467619  

2014
Patrick Barnable Giulia Calenda Louise Ouattara Agegnehu Gettie James Blanchard Ninochka Jean-Pierre Larisa Kizima Aixa Rodríguez Ciby Abraham Radhika Menon Samantha Seidor Michael L. Cooney Kevin D. Roberts Rhoda Sperling Michael Piatak Jeffrey D. Lifson Jose A. Fernandez-Romero Thomas M. Zydowsky Melissa Robbiani Natalia Teleshova Cheryl A. Stoddart

To extend our observations that single or repeated application of a gel containing the NNRTI MIV-150 (M) and zinc acetate dihydrate (ZA) in carrageenan (CG) (MZC) inhibits vaginal transmission of simian/human immunodeficiency virus (SHIV)-RT in macaques, we evaluated safety and anti-SHIV-RT activity of MZC and related gel formulations ex vivo in macaque mucosal explants. In addition, safety was...

Journal: :The Journal of infectious diseases 1999
N Bourne D I Bernstein J Ireland A J Sonderfan A T Profy L R Stanberry

Vaginal gel formulations containing the naphthalene sulfonate polymer PRO 2000 are being developed as topical microbicides to protect against infection with sexually transmitted disease (STD) pathogens. A mouse model was used to determine whether PRO 2000 could protect against genital herpes in vivo. Animals received a single intravaginal application of 15 microL of a 10% PRO 2000 aqueous solut...

2014
Larisa Kizima Aixa Rodríguez Jessica Kenney Nina Derby Olga Mizenina Radhika Menon Samantha Seidor Shimin Zhang Keith Levendosky Ninochka Jean-Pierre Pavel Pugach Guillermo Villegas Brian E. Ford Agegnehu Gettie James Blanchard Michael Piatak Jeffrey D. Lifson Gabriela Paglini Natalia Teleshova Thomas M. Zydowsky Melissa Robbiani José A. Fernández-Romero

Prevalent infection with human herpes simplex 2 (HSV-2) or human papillomavirus (HPV) is associated with increased human immunodeficiency virus (HIV) acquisition. Microbicides that target HIV as well as these sexually transmitted infections (STIs) may more effectively limit HIV incidence. Previously, we showed that a microbicide gel (MZC) containing MIV-150, zinc acetate (ZA) and carrageenan (C...

2014
Meredith R. Clark M. Melissa Peet Sarah Davis Gustavo F. Doncel David R. Friend

Vaginal tablets are being developed as an alternative to gels as an inexpensive, discreet dosage form for the administration of microbicides. This work describes the pharmacokinetic (PK) evaluation of rapidly disintegrating vaginal tablets containing tenofovir (TFV, 10 mg), emtricitabine (FTC, 10 mg), and the combination of TFV and FTC (10 mg each) under in vitro and in vivo conditions, and in ...

Journal: :European review for medical and pharmacological sciences 2003
S Gerli D Rossetti G C Di Renzo

BACKGROUND Bacterial vaginosis (BV) is the most common vulvovaginal infection and represents the 35% of all the infections occurring in women in the reproductive age. It is well recognised that serious forms of BV can induce several complications among women undergoing gynaecologic or obstetric surgery, having pelvic inflammatory diseases, temporary or absolute infertility, miscarriage and abor...

2013
Silvia Vailati Elsa Melloni Ermanno Riscassi Delphine Behr Roussel Marco Sardina

INTRODUCTION Vaginal dryness due to vaginal atrophy is a common complaint of postmenopausal women, interfering with sexual function and quality of life. Hormone replacement therapy is the only effective therapy but with known risks that leave unmet medical needs. A new product, ZP-025 vaginal gel, containing purified (dialyzed lyophilized) bovine colostrum, has been developed for the treatment ...

Journal: :Science translational medicine 2012
Rachel Singer Paul Mawson Nina Derby Aixa Rodriguez Larisa Kizima Radhika Menon Daniel Goldman Jessica Kenney Meropi Aravantinou Samantha Seidor Agegnehu Gettie James Blanchard Michael Piatak Jeffrey D Lifson José A Fernández-Romero Melissa Robbiani Thomas M Zydowsky

Microbicides may prevent HIV and sexually transmitted infections (STIs) in women; however, determining the optimal means of delivery of active pharmaceutical ingredients remains a major challenge. We previously demonstrated that a vaginal gel containing the non-nucleoside reverse transcriptase inhibitor MIV-150 partially protected macaques from SHIV-RT (simian/HIV reverse transcriptase) infecti...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید